J R Phillips1, M G Karlowicz. 1. Department of Pediatrics, Eastern Virginia Medical School, Children's Hospital of The King's Daughters, Norfolk 23507, USA.
Abstract
OBJECTIVE: To determine the prevalence and clinical features of Candida species in hospital-acquired urinary tract infections (UTI) in a neonatal intensive care unit. DESIGN: A retrospective study was conducted of hospital-acquired UTI occurring in infants admitted to a neonatal intensive care unit between January 1, 1989, and June 30, 1995. Hospital-acquired infection was defined as one occurring in an infant who was at least 7 days of age and hospitalized since birth. Urinary tract infection was defined by a urine culture yielding a single organism with > 1000 colony-forming units/ml from a suprapubic aspiration or > 10,000 colony-forming units/ml via urethral catheterization. RESULTS: Fifty-seven infants had 60 UTI during the study period. Candida spp. were responsible for 25 of 60 (42%) UTI. The median gestational age of infants with candidal UTI was 26 weeks (range, 23 to 37) which was significantly less than that for infants with bacterial UTI, 28 weeks (range, 23 to 40) (P = 0.04). Candidemia was present in 13 of 25 (52%) candidal UTI which was significantly more often than bacteremia with bacterial UTI, 3 of 35 (8%) (odds ratio, 11.6; 95% confidence interval, 2.8 to 47.8). The median age of infection for candidal UTI was 34 days (range, 9 to 228), which was significantly earlier than for bacterial UTI, 79 days (range, 7 to 247) (P = 0.003). Renal pelvis fungus balls were present in 7 of 20 (35%) infants with candidal UTI who had renal ultrasound studies. CONCLUSIONS: Candida spp. were the pathogens identified in 42% of hospital-acquired urinary tract infections in a neonatal intensive care unit. Candidemia was associated with 52% of candidal UTI and bacteremia with 8% of bacterial UTI. Candidal UTI occurred significantly earlier than bacterial UTI. Renal fungus balls were present in 35% of infants with candidal UTI.
OBJECTIVE: To determine the prevalence and clinical features of Candida species in hospital-acquired urinary tract infections (UTI) in a neonatal intensive care unit. DESIGN: A retrospective study was conducted of hospital-acquired UTI occurring in infants admitted to a neonatal intensive care unit between January 1, 1989, and June 30, 1995. Hospital-acquired infection was defined as one occurring in an infant who was at least 7 days of age and hospitalized since birth. Urinary tract infection was defined by a urine culture yielding a single organism with > 1000 colony-forming units/ml from a suprapubic aspiration or > 10,000 colony-forming units/ml via urethral catheterization. RESULTS: Fifty-seven infants had 60 UTI during the study period. Candida spp. were responsible for 25 of 60 (42%) UTI. The median gestational age of infants with candidal UTI was 26 weeks (range, 23 to 37) which was significantly less than that for infants with bacterial UTI, 28 weeks (range, 23 to 40) (P = 0.04). Candidemia was present in 13 of 25 (52%) candidal UTI which was significantly more often than bacteremia with bacterial UTI, 3 of 35 (8%) (odds ratio, 11.6; 95% confidence interval, 2.8 to 47.8). The median age of infection for candidal UTI was 34 days (range, 9 to 228), which was significantly earlier than for bacterial UTI, 79 days (range, 7 to 247) (P = 0.003). Renal pelvis fungus balls were present in 7 of 20 (35%) infants with candidal UTI who had renal ultrasound studies. CONCLUSIONS: Candida spp. were the pathogens identified in 42% of hospital-acquired urinary tract infections in a neonatal intensive care unit. Candidemia was associated with 52% of candidal UTI and bacteremia with 8% of bacterial UTI. Candidal UTI occurred significantly earlier than bacterial UTI. Renal fungus balls were present in 35% of infants with candidal UTI.
Authors: James L Wynn; Sylvia Tan; Marie G Gantz; Abhik Das; Ronald N Goldberg; Ira Adams-Chapman; Barbara J Stoll; Seetha Shankaran; Michele C Walsh; Kathy J Auten; Nancy A Miller; Pablo J Sánchez; Rosemary D Higgins; C Michael Cotten; P Brian Smith; Daniel K Benjamin Journal: Clin Infect Dis Date: 2011-12-05 Impact factor: 9.079
Authors: James L Wynn; Daniel K Benjamin; Daniel K Benjamin; Michael Cohen-Wolkowiez; Reese H Clark; P Brian Smith Journal: Early Hum Dev Date: 2011-09-15 Impact factor: 2.079
Authors: Kevin Watt; Paolo Manzoni; Michael Cohen-Wolkowiez; Stefano Rizzollo; Elena Boano; Evelyne Jacqz-Aigrain; Daniel K Benjamin Journal: Curr Drug Metab Date: 2013-02 Impact factor: 3.731
Authors: L C Downey; D K Benjamin; R H Clark; K M Watt; C P Hornik; M M Laughon; M Cohen-Wolkowiez; P B Smith Journal: J Perinatol Date: 2012-08-30 Impact factor: 2.521
Authors: Joan L Robinson; H Dele Davies; Michelle Barton; Karel O'Brien; Kim Simpson; Elizabeth Asztalos; Anne Synnes; Earl Rubin; Nicole Le Saux; Charles Hui; Joanne M Langley; Reg Sauve; Louis de Repentigny; Lajos Kovacs; Ben Tan; Susan E Richardson Journal: BMC Infect Dis Date: 2009-11-23 Impact factor: 3.090